Literature DB >> 22886411

Creatine kinase overexpression improves ATP kinetics and contractile function in postischemic myocardium.

Ashwin Akki1, Jason Su, Toshiyuki Yano, Ashish Gupta, Yibin Wang, Michelle K Leppo, Vadappuram P Chacko, Charles Steenbergen, Robert G Weiss.   

Abstract

Reduced myofibrillar ATP availability during prolonged myocardial ischemia may limit post-ischemic mechanical function. Because creatine kinase (CK) is the prime energy reserve reaction of the heart and because it has been difficult to augment ATP synthesis during and after ischemia, we used mice that overexpress the myofibrillar isoform of creatine kinase (CKM) in cardiac-specific, conditional fashion to test the hypothesis that CKM overexpression increases ATP delivery in ischemic-reperfused hearts and improves functional recovery. Isolated, retrograde-perfused hearts from control and CKM mice were subjected to 25 min of global, no-flow ischemia and 40 min of reperfusion while cardiac function [rate pressure product (RPP)] was monitored. A combination of (31)P-nuclear magnetic resonance experiments at 11.7T and biochemical assays was used to measure the myocardial rate of ATP synthesis via CK (CK flux) and intracellular pH (pH(i)). Baseline CK flux was severalfold higher in CKM hearts (8.1 ± 1.0 vs. 32.9 ± 3.8, mM/s, control vs. CKM; P < 0.001) with no differences in phosphocreatine concentration [PCr] and RPP. End-ischemic pH(i) was higher in CKM hearts than in control hearts (6.04 ± 0.12 vs. 6.37 ± 0.04, control vs. CKM; P < 0.05) with no differences in [PCr] and [ATP] between the two groups. Post-ischemic PCr (66.2 ± 1.3 vs. 99.1 ± 8.0, %preischemic levels; P < 0.01), CK flux (3.2 ± 0.4 vs. 14.0 ± 1.2 mM/s; P < 0.001) and functional recovery (13.7 ± 3.4 vs. 64.9 ± 13.2%preischemic RPP; P < 0.01) were significantly higher and lactate dehydrogenase release was lower in CKM than in control hearts. Thus augmenting cardiac CKM expression attenuates ischemic acidosis, reduces injury, and improves not only high-energy phosphate content and the rate of CK ATP synthesis in postischemic myocardium but also recovery of contractile function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886411      PMCID: PMC3469706          DOI: 10.1152/ajpheart.00268.2012

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  43 in total

1.  Phosphorus nuclear magnetic resonance of perfused working rat hearts.

Authors:  W E Jacobus; G J Taylor; D P Hollis; R L Nunnally
Journal:  Nature       Date:  1977-02-24       Impact factor: 49.962

2.  Analysis of control of glycolysis in ischemic hearts having heterogeneous zones of anoxia.

Authors:  C Steenbergen; G Deleeuw; J R Williamson
Journal:  J Mol Cell Cardiol       Date:  1978-07       Impact factor: 5.000

3.  Effects of acidosis and ischemia on contractility and intracellular pH of rat heart.

Authors:  C Steenbergen; G Deleeuw; T Rich; J R Williamson
Journal:  Circ Res       Date:  1977-12       Impact factor: 17.367

4.  Chronic high-dose creatine feeding does not attenuate left ventricular remodeling in rat hearts post-myocardial infarction.

Authors:  M Horn; H Remkes; C Dienesch; K Hu; G Ertl; S Neubauer
Journal:  Cardiovasc Res       Date:  1999-07       Impact factor: 10.787

5.  ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate.

Authors:  A C Cave; J S Ingwall; J Friedrich; R Liao; K W Saupe; C S Apstein; F R Eberli
Journal:  Circulation       Date:  2000-05-02       Impact factor: 29.690

6.  Kinetic, thermodynamic, and developmental consequences of deleting creatine kinase isoenzymes from the heart. Reaction kinetics of the creatine kinase isoenzymes in the intact heart.

Authors:  K W Saupe; M Spindler; J C Hopkins; W Shen; J S Ingwall
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

7.  Modeling the energy transfer pathways. creatine kinase activities and heterogeneous distribution of ADP in the perfused heart.

Authors:  F Joubert; J A Hoerter; J L Mazet
Journal:  Mol Biol Rep       Date:  2002       Impact factor: 2.316

8.  Creatine kinase-deficient hearts exhibit increased susceptibility to ischemia-reperfusion injury and impaired calcium homeostasis.

Authors:  Matthias Spindler; Klaus Meyer; Hinrik Strömer; Andrea Leupold; Ernest Boehm; Helga Wagner; Stefan Neubauer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-04-22       Impact factor: 4.733

9.  Importance of creatine kinase activity for functional recovery of myocardium after ischemia-reperfusion challenge.

Authors:  Patricia Rodriguez; Martin Avellanal; Antonio Felizola; Santos Barrigon
Journal:  J Cardiovasc Pharmacol       Date:  2003-01       Impact factor: 3.105

Review 10.  Molecular system bioenergics of the heart: experimental studies of metabolic compartmentation and energy fluxes versus computer modeling.

Authors:  Mayis Aliev; Rita Guzun; Minna Karu-Varikmaa; Tuuli Kaambre; Theo Wallimann; Valdur Saks
Journal:  Int J Mol Sci       Date:  2011-12-13       Impact factor: 5.923

View more
  14 in total

Review 1.  A comprehensive review of the bioenergetics of fatty acid and glucose metabolism in the healthy and failing heart in nondiabetic condition.

Authors:  Ashish Gupta; Brian Houston
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 2.  Ontogeny of cardiomyocytes: ultrastructure optimization to meet the demand for tight communication in excitation-contraction coupling and energy transfer.

Authors:  Rikke Birkedal; Martin Laasmaa; Jelena Branovets; Marko Vendelin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2022-10-03       Impact factor: 6.671

Review 3.  Age-related changes of myocardial ATP supply and demand mechanisms.

Authors:  Yael Yaniv; Magdalena Juhaszova; Steven J Sollott
Journal:  Trends Endocrinol Metab       Date:  2013-07-08       Impact factor: 12.015

4.  Normal cardiac function in mice with supraphysiological cardiac creatine levels.

Authors:  Lucia Santacruz; Alejandro Hernandez; Jeffrey Nienaber; Rajashree Mishra; Miguel Pinilla; James Burchette; Lan Mao; Howard A Rockman; Danny O Jacobs
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-22       Impact factor: 4.733

Review 5.  The Pitfalls of in vivo Cardiac Physiology in Genetically Modified Mice - Lessons Learnt the Hard Way in the Creatine Kinase System.

Authors:  Craig A Lygate
Journal:  Front Physiol       Date:  2021-05-14       Impact factor: 4.566

Review 6.  A link between ATP and SUR2A: A novel mechanism explaining cardioprotection at high altitude.

Authors:  Khaja Shameem Mohammed Abdul; Sofija Jovanović; Qingyou Du; Andriy Sukhodub; Aleksandar Jovanović
Journal:  Int J Cardiol       Date:  2015-04-11       Impact factor: 4.164

7.  The location of energetic compartments affects energetic communication in cardiomyocytes.

Authors:  Rikke Birkedal; Martin Laasmaa; Marko Vendelin
Journal:  Front Physiol       Date:  2014-09-29       Impact factor: 4.566

8.  Increasing creatine kinase activity protects against hypoxia / reoxygenation injury but not against anthracycline toxicity in vitro.

Authors:  Sevasti Zervou; Hannah J Whittington; Philip J Ostrowski; Fang Cao; Jack Tyler; Hannah A Lake; Stefan Neubauer; Craig A Lygate
Journal:  PLoS One       Date:  2017-08-14       Impact factor: 3.240

Review 9.  Modular organization of cardiac energy metabolism: energy conversion, transfer and feedback regulation.

Authors:  R Guzun; T Kaambre; R Bagur; A Grichine; Y Usson; M Varikmaa; T Anmann; K Tepp; N Timohhina; I Shevchuk; V Chekulayev; F Boucher; P Dos Santos; U Schlattner; T Wallimann; A V Kuznetsov; P Dzeja; M Aliev; V Saks
Journal:  Acta Physiol (Oxf)       Date:  2014-04-18       Impact factor: 6.311

10.  Protective Effect of Creatine Elevation against Ischaemia Reperfusion Injury Is Retained in the Presence of Co-Morbidities and during Cardioplegia.

Authors:  Hannah J Whittington; Debra J McAndrew; Rebecca L Cross; Stefan Neubauer; Craig A Lygate
Journal:  PLoS One       Date:  2016-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.